MN42–81: A novel PD-L1-targeted immunomodulatory cisplatin prodrug for highly efficient synergistic chemo-immunotherapy of cancer
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Metal complexes synthesis and properties
Nanoparticle-Based Drug Delivery
Publication details
- Journal / source
- Bioorganic & Medicinal Chemistry
- Volume
- 137
- Pages
- 118629–118629
- Publication date
- 13 March 2026
- Language
- EN